According to a new report, published by KBV research, The Global Cell Cryopreservation Market size is expected to reach $35.7 billion by 2030, rising at a market growth of 20.3% CAGR during the forecast period.
The Cell Freezing Media segment is experiencing a CAGR of 20.8% during (2023 - 2030). The primary function of cell freezing media is to protect cells from damage caused by ice crystal formation during the freezing process. Cryoprotective agents within the media reduce the formation of ice crystals in and around the cells. Cell freezing media help maintain the integrity of the cell membrane, preventing cell rupture and maintaining the functional and structural properties of the cells. Cryopreservation solutions are designed to be consistent and reproducible in their effects, allowing for standardized protocols in research and clinical applications.
The IVF clinics segment is generating the highest revenue in the Global Cell Cryopreservation Market by End-use in 2022; thereby, achieving a market value of $12.5 billion by 2030. IVF clinics often operate or partner with sperm and egg banks to provide gamete cryopreservation services. Individuals and couples may choose to bank their sperm or eggs for future fertility preservation, even before undergoing any assisted reproductive procedures. IVF clinics routinely freeze and store surplus embryos after an IVF cycle. Embryos can be cryopreserved while the selection process is ongoing. Their role is central to helping individuals and couples overcome infertility and achieve family-building goals.
The Oocytes & Embryotic cells segment is exhibiting a CAGR of 20% during (2023 - 2030). The segment is predicted to expand rapidly due to an increase in the number of egg-freezing cycles, an increase in stem cell R&D activities, an increase in biobanks, and a surge in demand for personalized pharmaceuticals. Extracting and freezing a woman's eggs for future use is known as egg freezing or oocyte cryopreservation. This approach has grown in recent years due to the possible benefits it offers, such as preserving fertility opportunities for women who want to postpone children or are at risk of fertility disorders.
The North America region dominated the Global Cell Cryopreservation Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $12.6 billion by 2030. The Europe market is anticipated to grow a CAGR of 19.9% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 21.1% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/cell-cryopreservation-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Merck KGaA, Thermo Fisher Scientific, Inc., Sartorius AG, PromoCell GmbH, Lonza Group Ltd., HiMedia Laboratories Pvt. Ltd., Corning Incorporated, BioLife Solutions, Inc., Eppendorf SE and Danaher Corporation.
By Component
By End-use
By Application
By Geography
Companies Profiled
Unique Offerings 
